Literature DB >> 32286894

Effects of Cacao By-Products and a Modest Weight Loss Intervention on the Concentration of Serum Triglycerides in Overweight Subjects: Proof of Concept.

Perla León-Flores1, Nayelli Nájera1, Elizabeth Pérez2, Blanca Pardo2, Fiacro Jimenez3, Dylan Diaz-Chiguer3, Francisco Villarreal4, Isabel Hidalgo1, Guillermo Ceballos1, Eduardo Meaney1.   

Abstract

Therapeutic approaches to decrease serum triglyceride (TG) concentrations are not successful mainly due to poor adherence or adverse effects of therapies. In consequence, the search for new low-cost and safer therapeutic alternatives is mandatory. Dark chocolate and cacao have shown promising results improving lipid profiles. Recently, using cacao by-products to reduce elevated cardiometabolic risk markers in an animal model of obesity induced by a high-fat diet and fructose, we showed that TGs, low-density lipoprotein cholesterol, and the TG/high-density lipoprotein (HDL) ratio decreased, suggesting that cacao by-products improved the metabolic function of obese animals. Based on these results, as a proof of concept, a blinded placebo-controlled study was implemented to explore the effects of cacao by-products on anthropometric and biochemical variables in a group of overweight subjects participating in a program composed of reduced-calorie-diet counseling plus a simple aerobic exercise plan. The results showed that counseling induced weight and abdominal circumference reductions in both groups. TGs did not change in the control group; however, TG decreased significantly by 54.9 mg/dL (27.9%) in the experimental group. The TG/HDL cholesterol ratio changed markedly (1.5) in the experimental group. The results reported suggest the use of cacao by-products as an alternative for the treatment of hypertriglyceridemia.

Entities:  

Keywords:  cacao by-products; hypertriglyceridemia; obesity

Mesh:

Substances:

Year:  2020        PMID: 32286894      PMCID: PMC7370978          DOI: 10.1089/jmf.2019.0201

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  22 in total

Review 1.  Metabolic syndrome: focus on dyslipidemia.

Authors:  Henry N Ginsberg; Yuan-Li Zhang; Antonio Hernandez-Ono
Journal:  Obesity (Silver Spring)       Date:  2006-02       Impact factor: 5.002

2.  2011 Compendium of Physical Activities: a second update of codes and MET values.

Authors:  Barbara E Ainsworth; William L Haskell; Stephen D Herrmann; Nathanael Meckes; David R Bassett; Catrine Tudor-Locke; Jennifer L Greer; Jesse Vezina; Melicia C Whitt-Glover; Arthur S Leon
Journal:  Med Sci Sports Exerc       Date:  2011-08       Impact factor: 5.411

Review 3.  Link between Metabolic Syndrome and Insulin Resistance.

Authors:  Zoran Gluvic; Bozidarka Zaric; Ivana Resanovic; Milan Obradovic; Aleksandar Mitrovic; Djordje Radak; Esma R Isenovic
Journal:  Curr Vasc Pharmacol       Date:  2017       Impact factor: 2.719

Review 4.  Cocoa and chocolate in human health and disease.

Authors:  David L Katz; Kim Doughty; Ather Ali
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

5.  Cardiovascular risk factors in a Mexican middle-class urban population. The Lindavista Study. Baseline data.

Authors:  Alejandra Meaney; Guillermo Ceballos-Reyes; Gabriela Gutiérrez-Salmean; Virginia Samaniego-Méndez; Agustín Vela-Huerta; Luis Alcocer; Elisa Zárate-Chavarría; Emma Mendoza-Castelán; Ivonne Olivares-Corichi; Rubén García-Sánchez; Yolanda Martínez-Marroquín; Israel Ramírez-Sánchez; Eduardo Meaney
Journal:  Arch Cardiol Mex       Date:  2013-11-09

6.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

7.  Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors.

Authors:  Gabriel Gutiérrez-Salmeán; Pilar Ortiz-Vilchis; Claudia Maria Vacaseydel; Leticia Garduño-Siciliano; German Chamorro-Cevallos; Eduardo Meaney; Santiago Villafaña; Francisco Villarreal; Guillermo Ceballos; Israel Ramírez-Sánchez
Journal:  Eur J Pharmacol       Date:  2014-01-31       Impact factor: 4.432

8.  Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.

Authors:  G Assmann; H Schulte
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

9.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

Review 10.  Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.

Authors:  Simon Barquera; Ismael Campos-Nonato; Carlos Aguilar-Salinas; Ruy Lopez-Ridaura; Armando Arredondo; Juan Rivera-Dommarco
Journal:  Global Health       Date:  2013-02-02       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.